Review



sino biological catalog 50385 mnac  (Sino Biological)


Bioz Verified Symbol Sino Biological is a verified supplier
Bioz Manufacturer Symbol Sino Biological manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Sino Biological sino biological catalog 50385 mnac
    Sino Biological Catalog 50385 Mnac, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sino biological catalog 50385 mnac/product/Sino Biological
    Average 94 stars, based on 10 article reviews
    sino biological catalog 50385 mnac - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Sino Biological sino biological catalog 50385 mnac
    Sino Biological Catalog 50385 Mnac, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sino biological catalog 50385 mnac/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    sino biological catalog 50385 mnac - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Sino Biological sino biological catalog
    ( A ) Diversity of influenza A HA. Phylogenetic tree of IAV HAs (left). Timeline of <t>influenza</t> <t>H1N1</t> and H3N2 circulation; symbols represent strains used in this study (middle). Pairwise identity of HAs from viruses used in this study mapped onto structures of HA [Protein Data Bank (PDB) 3LZG and 4FNK] (right). ( B ) Neutralization potencies determined by microneutralization for down-selected antibodies against a panel of IAVs. Strains are indicated as in (A). H1N1 strains: A/WSN/1933, A/USSR/90/1977, A/Memphis/4/1987, A/Massachusetts/1/1990, A/Beijing/262/1995, A/New Caledonia/20/1999, A/Solomon Islands/3/2006, A/New York/08-1326/2008, A/California/07/2009, A/Michigan/45/2015, and A/Sydney/5/2021. H3N2 strains: A/Aichi/2/1968, A/Bilthoven/1761/1976, A/Beijing/353/1989, A/Johannesburg/33/1994, A/Brisbane/8/1996, A/Fujian/411/2002, A/Wisconsin/67/2005, A/Perth/16/2009, A/Switzerland/9715293/2013, and A/Kansas/14/2017. Neutralization assays were performed in technical duplicate. N.N., non-neutralizing. ( C ) ELISA binding reactivity at 10 or 1 μg/ml to A/Swine/Henan/SN13/2018 or A/Canine/Hainan/79/2019 (left) and BLI-based antibody competition with the indicated antibodies (right).
    Sino Biological Catalog, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sino biological catalog/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    sino biological catalog - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    95
    Sino Biological s1 catalog 40591 v08b1 sino biological beijing china
    ( A ) Diversity of influenza A HA. Phylogenetic tree of IAV HAs (left). Timeline of <t>influenza</t> <t>H1N1</t> and H3N2 circulation; symbols represent strains used in this study (middle). Pairwise identity of HAs from viruses used in this study mapped onto structures of HA [Protein Data Bank (PDB) 3LZG and 4FNK] (right). ( B ) Neutralization potencies determined by microneutralization for down-selected antibodies against a panel of IAVs. Strains are indicated as in (A). H1N1 strains: A/WSN/1933, A/USSR/90/1977, A/Memphis/4/1987, A/Massachusetts/1/1990, A/Beijing/262/1995, A/New Caledonia/20/1999, A/Solomon Islands/3/2006, A/New York/08-1326/2008, A/California/07/2009, A/Michigan/45/2015, and A/Sydney/5/2021. H3N2 strains: A/Aichi/2/1968, A/Bilthoven/1761/1976, A/Beijing/353/1989, A/Johannesburg/33/1994, A/Brisbane/8/1996, A/Fujian/411/2002, A/Wisconsin/67/2005, A/Perth/16/2009, A/Switzerland/9715293/2013, and A/Kansas/14/2017. Neutralization assays were performed in technical duplicate. N.N., non-neutralizing. ( C ) ELISA binding reactivity at 10 or 1 μg/ml to A/Swine/Henan/SN13/2018 or A/Canine/Hainan/79/2019 (left) and BLI-based antibody competition with the indicated antibodies (right).
    S1 Catalog 40591 V08b1 Sino Biological Beijing China, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s1 catalog 40591 v08b1 sino biological beijing china/product/Sino Biological
    Average 95 stars, based on 1 article reviews
    s1 catalog 40591 v08b1 sino biological beijing china - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    Sino Biological recombinant sino biological catalog no 51061 mnae recombinant mouse m csf protein r d systems catalog no
    ( A ) Diversity of influenza A HA. Phylogenetic tree of IAV HAs (left). Timeline of <t>influenza</t> <t>H1N1</t> and H3N2 circulation; symbols represent strains used in this study (middle). Pairwise identity of HAs from viruses used in this study mapped onto structures of HA [Protein Data Bank (PDB) 3LZG and 4FNK] (right). ( B ) Neutralization potencies determined by microneutralization for down-selected antibodies against a panel of IAVs. Strains are indicated as in (A). H1N1 strains: A/WSN/1933, A/USSR/90/1977, A/Memphis/4/1987, A/Massachusetts/1/1990, A/Beijing/262/1995, A/New Caledonia/20/1999, A/Solomon Islands/3/2006, A/New York/08-1326/2008, A/California/07/2009, A/Michigan/45/2015, and A/Sydney/5/2021. H3N2 strains: A/Aichi/2/1968, A/Bilthoven/1761/1976, A/Beijing/353/1989, A/Johannesburg/33/1994, A/Brisbane/8/1996, A/Fujian/411/2002, A/Wisconsin/67/2005, A/Perth/16/2009, A/Switzerland/9715293/2013, and A/Kansas/14/2017. Neutralization assays were performed in technical duplicate. N.N., non-neutralizing. ( C ) ELISA binding reactivity at 10 or 1 μg/ml to A/Swine/Henan/SN13/2018 or A/Canine/Hainan/79/2019 (left) and BLI-based antibody competition with the indicated antibodies (right).
    Recombinant Sino Biological Catalog No 51061 Mnae Recombinant Mouse M Csf Protein R D Systems Catalog No, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant sino biological catalog no 51061 mnae recombinant mouse m csf protein r d systems catalog no/product/Sino Biological
    Average 95 stars, based on 1 article reviews
    recombinant sino biological catalog no 51061 mnae recombinant mouse m csf protein r d systems catalog no - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    94
    Sino Biological ifn β sino biological catalog no 10704 hnas
    A) Human lung epithelial Calu-3 cells were infected with SARS-CoV-2 (MOI= 0.1). Whole cell lysate (WCL) collected at 48h post-infection (hpi) and 120hpi was subjected to immunoblotting with ISG15, PLpro and actin antibodies. B) Cell culture supernatants (supernatant) from SARS-CoV-2 (MOI= 0.1) infected Calu-3 cells were collected at 120 hours post infection. Trichloroacetic acid (TCA) precipitated supernatant was subjected to immunoblot with anti-ISG15 antibody to detect extracellular ISG15. C) Supernatants from mock and SARS-CoV-2 infected (120 hpi) Calu-3 cells were used to quantify cell death by lactate dehydrogenase (LDH) assay. D) Experimental schematic – human lung epithelial A549 cells were transfected with either plasmids encoding C9-tagged S proteins from various coronaviruses or empty vector control plasmid pcDNA 3.1 (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 16h and 24h. Whole cell lysate (WCL) was collected for analysis. E) WCL collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15, C9, and actin antibodies. A549 cells treated with <t>interferon-β</t> <t>(IFN-β,</t> 100U/mL) for 24 was used as a positive control for ISGylation. F) A549 cells were transfected with C9-tagged S protein from various coronaviruses including MERS-CoV (MERS), 229E, SARS-CoV-2 (SARS2) and SARS-CoV-1 (SARS1) or empty vector control (pcDNA). The experiment was conducted as described in the experimental scheme shown in . WCL collected at 24h was subjected to immunoblotting with ISG15, C9, and actin antibodies. G) Experimental schematic - A549 cells were transfected with either plasmid encoding C9-tagged SARS-CoV-2 S protein or empty vector control (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 8h, 16h and 24h. Total protein in plasmid-free culture supernatant was precipitated with TCA. H) TCA precipitated culture supernatant collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15 antibody to detect extracellularly released ISG15.
    Ifn β Sino Biological Catalog No 10704 Hnas, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifn β sino biological catalog no 10704 hnas/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    ifn β sino biological catalog no 10704 hnas - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Sino Biological anti pedf catalog no 11104 rp02 sino biological beijing china
    A) Human lung epithelial Calu-3 cells were infected with SARS-CoV-2 (MOI= 0.1). Whole cell lysate (WCL) collected at 48h post-infection (hpi) and 120hpi was subjected to immunoblotting with ISG15, PLpro and actin antibodies. B) Cell culture supernatants (supernatant) from SARS-CoV-2 (MOI= 0.1) infected Calu-3 cells were collected at 120 hours post infection. Trichloroacetic acid (TCA) precipitated supernatant was subjected to immunoblot with anti-ISG15 antibody to detect extracellular ISG15. C) Supernatants from mock and SARS-CoV-2 infected (120 hpi) Calu-3 cells were used to quantify cell death by lactate dehydrogenase (LDH) assay. D) Experimental schematic – human lung epithelial A549 cells were transfected with either plasmids encoding C9-tagged S proteins from various coronaviruses or empty vector control plasmid pcDNA 3.1 (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 16h and 24h. Whole cell lysate (WCL) was collected for analysis. E) WCL collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15, C9, and actin antibodies. A549 cells treated with <t>interferon-β</t> <t>(IFN-β,</t> 100U/mL) for 24 was used as a positive control for ISGylation. F) A549 cells were transfected with C9-tagged S protein from various coronaviruses including MERS-CoV (MERS), 229E, SARS-CoV-2 (SARS2) and SARS-CoV-1 (SARS1) or empty vector control (pcDNA). The experiment was conducted as described in the experimental scheme shown in . WCL collected at 24h was subjected to immunoblotting with ISG15, C9, and actin antibodies. G) Experimental schematic - A549 cells were transfected with either plasmid encoding C9-tagged SARS-CoV-2 S protein or empty vector control (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 8h, 16h and 24h. Total protein in plasmid-free culture supernatant was precipitated with TCA. H) TCA precipitated culture supernatant collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15 antibody to detect extracellularly released ISG15.
    Anti Pedf Catalog No 11104 Rp02 Sino Biological Beijing China, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pedf catalog no 11104 rp02 sino biological beijing china/product/Sino Biological
    Average 93 stars, based on 1 article reviews
    anti pedf catalog no 11104 rp02 sino biological beijing china - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Sino Biological anti ccl20 sino biological catalog no 10485 t24
    A) Human lung epithelial Calu-3 cells were infected with SARS-CoV-2 (MOI= 0.1). Whole cell lysate (WCL) collected at 48h post-infection (hpi) and 120hpi was subjected to immunoblotting with ISG15, PLpro and actin antibodies. B) Cell culture supernatants (supernatant) from SARS-CoV-2 (MOI= 0.1) infected Calu-3 cells were collected at 120 hours post infection. Trichloroacetic acid (TCA) precipitated supernatant was subjected to immunoblot with anti-ISG15 antibody to detect extracellular ISG15. C) Supernatants from mock and SARS-CoV-2 infected (120 hpi) Calu-3 cells were used to quantify cell death by lactate dehydrogenase (LDH) assay. D) Experimental schematic – human lung epithelial A549 cells were transfected with either plasmids encoding C9-tagged S proteins from various coronaviruses or empty vector control plasmid pcDNA 3.1 (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 16h and 24h. Whole cell lysate (WCL) was collected for analysis. E) WCL collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15, C9, and actin antibodies. A549 cells treated with <t>interferon-β</t> <t>(IFN-β,</t> 100U/mL) for 24 was used as a positive control for ISGylation. F) A549 cells were transfected with C9-tagged S protein from various coronaviruses including MERS-CoV (MERS), 229E, SARS-CoV-2 (SARS2) and SARS-CoV-1 (SARS1) or empty vector control (pcDNA). The experiment was conducted as described in the experimental scheme shown in . WCL collected at 24h was subjected to immunoblotting with ISG15, C9, and actin antibodies. G) Experimental schematic - A549 cells were transfected with either plasmid encoding C9-tagged SARS-CoV-2 S protein or empty vector control (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 8h, 16h and 24h. Total protein in plasmid-free culture supernatant was precipitated with TCA. H) TCA precipitated culture supernatant collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15 antibody to detect extracellularly released ISG15.
    Anti Ccl20 Sino Biological Catalog No 10485 T24, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ccl20 sino biological catalog no 10485 t24/product/Sino Biological
    Average 93 stars, based on 1 article reviews
    anti ccl20 sino biological catalog no 10485 t24 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Diversity of influenza A HA. Phylogenetic tree of IAV HAs (left). Timeline of influenza H1N1 and H3N2 circulation; symbols represent strains used in this study (middle). Pairwise identity of HAs from viruses used in this study mapped onto structures of HA [Protein Data Bank (PDB) 3LZG and 4FNK] (right). ( B ) Neutralization potencies determined by microneutralization for down-selected antibodies against a panel of IAVs. Strains are indicated as in (A). H1N1 strains: A/WSN/1933, A/USSR/90/1977, A/Memphis/4/1987, A/Massachusetts/1/1990, A/Beijing/262/1995, A/New Caledonia/20/1999, A/Solomon Islands/3/2006, A/New York/08-1326/2008, A/California/07/2009, A/Michigan/45/2015, and A/Sydney/5/2021. H3N2 strains: A/Aichi/2/1968, A/Bilthoven/1761/1976, A/Beijing/353/1989, A/Johannesburg/33/1994, A/Brisbane/8/1996, A/Fujian/411/2002, A/Wisconsin/67/2005, A/Perth/16/2009, A/Switzerland/9715293/2013, and A/Kansas/14/2017. Neutralization assays were performed in technical duplicate. N.N., non-neutralizing. ( C ) ELISA binding reactivity at 10 or 1 μg/ml to A/Swine/Henan/SN13/2018 or A/Canine/Hainan/79/2019 (left) and BLI-based antibody competition with the indicated antibodies (right).

    Journal: Science Advances

    Article Title: Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies

    doi: 10.1126/sciadv.adu9140

    Figure Lengend Snippet: ( A ) Diversity of influenza A HA. Phylogenetic tree of IAV HAs (left). Timeline of influenza H1N1 and H3N2 circulation; symbols represent strains used in this study (middle). Pairwise identity of HAs from viruses used in this study mapped onto structures of HA [Protein Data Bank (PDB) 3LZG and 4FNK] (right). ( B ) Neutralization potencies determined by microneutralization for down-selected antibodies against a panel of IAVs. Strains are indicated as in (A). H1N1 strains: A/WSN/1933, A/USSR/90/1977, A/Memphis/4/1987, A/Massachusetts/1/1990, A/Beijing/262/1995, A/New Caledonia/20/1999, A/Solomon Islands/3/2006, A/New York/08-1326/2008, A/California/07/2009, A/Michigan/45/2015, and A/Sydney/5/2021. H3N2 strains: A/Aichi/2/1968, A/Bilthoven/1761/1976, A/Beijing/353/1989, A/Johannesburg/33/1994, A/Brisbane/8/1996, A/Fujian/411/2002, A/Wisconsin/67/2005, A/Perth/16/2009, A/Switzerland/9715293/2013, and A/Kansas/14/2017. Neutralization assays were performed in technical duplicate. N.N., non-neutralizing. ( C ) ELISA binding reactivity at 10 or 1 μg/ml to A/Swine/Henan/SN13/2018 or A/Canine/Hainan/79/2019 (left) and BLI-based antibody competition with the indicated antibodies (right).

    Article Snippet: Briefly, His-tagged H1N1 A/California/04/2009 full-length trimer Y97F (Sino Biological, catalog no. 11055-V08B1) was mixed in 4:1 molar ratios with SA-allophycocyanin (APC; Invitrogen) and SA-phycoerythrin (PE; Invitrogen) whereas A/Darwin/6/2021 full-length soluble trimer and A/Hong Kong/1/1968 head trimer (see below) were mixed in 4:1 molar ratios with SA-PE (Invitrogen) and SA-APC (Invitrogen), respectively, and were incubated for 20 min on ice.

    Techniques: Neutralization, Enzyme-linked Immunosorbent Assay, Binding Assay

    A) Human lung epithelial Calu-3 cells were infected with SARS-CoV-2 (MOI= 0.1). Whole cell lysate (WCL) collected at 48h post-infection (hpi) and 120hpi was subjected to immunoblotting with ISG15, PLpro and actin antibodies. B) Cell culture supernatants (supernatant) from SARS-CoV-2 (MOI= 0.1) infected Calu-3 cells were collected at 120 hours post infection. Trichloroacetic acid (TCA) precipitated supernatant was subjected to immunoblot with anti-ISG15 antibody to detect extracellular ISG15. C) Supernatants from mock and SARS-CoV-2 infected (120 hpi) Calu-3 cells were used to quantify cell death by lactate dehydrogenase (LDH) assay. D) Experimental schematic – human lung epithelial A549 cells were transfected with either plasmids encoding C9-tagged S proteins from various coronaviruses or empty vector control plasmid pcDNA 3.1 (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 16h and 24h. Whole cell lysate (WCL) was collected for analysis. E) WCL collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15, C9, and actin antibodies. A549 cells treated with interferon-β (IFN-β, 100U/mL) for 24 was used as a positive control for ISGylation. F) A549 cells were transfected with C9-tagged S protein from various coronaviruses including MERS-CoV (MERS), 229E, SARS-CoV-2 (SARS2) and SARS-CoV-1 (SARS1) or empty vector control (pcDNA). The experiment was conducted as described in the experimental scheme shown in . WCL collected at 24h was subjected to immunoblotting with ISG15, C9, and actin antibodies. G) Experimental schematic - A549 cells were transfected with either plasmid encoding C9-tagged SARS-CoV-2 S protein or empty vector control (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 8h, 16h and 24h. Total protein in plasmid-free culture supernatant was precipitated with TCA. H) TCA precipitated culture supernatant collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15 antibody to detect extracellularly released ISG15.

    Journal: bioRxiv

    Article Title: Extracellular ISG15 triggers ISGylation via a type-I interferon independent mechanism to regulate host response during virus infection

    doi: 10.1101/2024.07.05.602290

    Figure Lengend Snippet: A) Human lung epithelial Calu-3 cells were infected with SARS-CoV-2 (MOI= 0.1). Whole cell lysate (WCL) collected at 48h post-infection (hpi) and 120hpi was subjected to immunoblotting with ISG15, PLpro and actin antibodies. B) Cell culture supernatants (supernatant) from SARS-CoV-2 (MOI= 0.1) infected Calu-3 cells were collected at 120 hours post infection. Trichloroacetic acid (TCA) precipitated supernatant was subjected to immunoblot with anti-ISG15 antibody to detect extracellular ISG15. C) Supernatants from mock and SARS-CoV-2 infected (120 hpi) Calu-3 cells were used to quantify cell death by lactate dehydrogenase (LDH) assay. D) Experimental schematic – human lung epithelial A549 cells were transfected with either plasmids encoding C9-tagged S proteins from various coronaviruses or empty vector control plasmid pcDNA 3.1 (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 16h and 24h. Whole cell lysate (WCL) was collected for analysis. E) WCL collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15, C9, and actin antibodies. A549 cells treated with interferon-β (IFN-β, 100U/mL) for 24 was used as a positive control for ISGylation. F) A549 cells were transfected with C9-tagged S protein from various coronaviruses including MERS-CoV (MERS), 229E, SARS-CoV-2 (SARS2) and SARS-CoV-1 (SARS1) or empty vector control (pcDNA). The experiment was conducted as described in the experimental scheme shown in . WCL collected at 24h was subjected to immunoblotting with ISG15, C9, and actin antibodies. G) Experimental schematic - A549 cells were transfected with either plasmid encoding C9-tagged SARS-CoV-2 S protein or empty vector control (pcDNA). At 24h post-transfection, washed cells were incubated with fresh media without plasmids for 8h, 16h and 24h. Total protein in plasmid-free culture supernatant was precipitated with TCA. H) TCA precipitated culture supernatant collected from A549 cells transfected with C9-tagged SARS-CoV-2 (SARS2) S protein as described in the experimental schematic in was subjected to immunoblotting with ISG15 antibody to detect extracellularly released ISG15.

    Article Snippet: Cells were treated with 500 U/ml of IFN-β (Sino Biological, catalog no. 10704-HNAS) or vehicle prepared in antibiotic free DMEM supplemented with 10% FBS.

    Techniques: Infection, Western Blot, Cell Culture, Lactate Dehydrogenase Assay, Transfection, Plasmid Preparation, Control, Incubation, Positive Control